QUARTERLY RESULTS
Alembic Pharmaceuticals Ltd.
BSE
Jun 02, 04:01
994.95
-22.25 ( -2.19%)
Volume
7347
Prev. Close
1017.20
Open Price
1017.40
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:49
996.00
-22.05 ( -2.17%)
Volume
70556
Prev. Close
1018.05
Open Price
1010.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
996.00 (84)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE901L01018
|
Market Cap. ( ₹ in Cr. )
|
19577.69
|
P/BV
|
4.01
|
Book Value ( ₹ )
|
248.68
|
|
BSE Code
|
533573
|
52 Week High/Low ( ₹ )
|
1304/725
|
FV/ML
|
2/1
|
P/E(X)
|
33.56
|
|
NSE Code
|
APLLTDEQ
|
Book Closure
|
15/07/2024
|
EPS ( ₹ )
|
29.68
|
Div Yield (%)
|
1.10
|
(₹ in Crs.)
| Net Sales/Income from operations | 1570.64 | 1406.09 | 1580.35 | 1475.56 | 1474.55 |
| Total Income From Operations | 1570.64 | 1406.09 | 1580.35 | 1475.56 | 1474.55 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 426.20 | 446.91 | 393.14 | 405.93 | 337.38 |
| Purchase of Traded Goods | 89.54 | 105.13 | 96.10 | 94.36 | 109.20 |
| Increase/Decrease in Stocks | 34.06 | -173.73 | -17.19 | -111.68 | -25.25 |
| Employees Cost | 373.27 | 369.18 | 367.61 | 356.51 | 354.92 |
| Depreciation | 68.60 | 69.69 | 70.12 | 68.68 | 69.12 |
| Other Expenses | 476.91 | 478.77 | 481.20 | 439.01 | 410.11 |
| Total Expenses | 1468.58 | 1295.95 | 1390.98 | 1252.81 | 1255.48 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 102.06 | 110.14 | 189.37 | 222.75 | 219.07 |
| Other Income | 13.21 | 15.46 | 16.06 | 3.15 | 7.22 |
| P/L Before Interest, Excpt. Items & Tax | 115.27 | 125.60 | 205.43 | 225.89 | 226.29 |
| Interest | 23.71 | 21.79 | 18.28 | 12.69 | 10.13 |
| P/L Before Exceptional Items & Tax | 91.56 | 103.81 | 187.15 | 213.20 | 216.16 |
| Exceptional Items | 0.00 | 0.00 | 12.87 | 0.00 | 0.00 |
| P/L Before Tax | 91.56 | 103.81 | 200.02 | 213.20 | 216.16 |
| Tax | 16.22 | 18.00 | 34.24 | 37.01 | 14.29 |
| P/L After Tax from Ordinary Activities | 75.34 | 85.81 | 165.78 | 176.19 | 201.87 |
| Net Profit/Loss For the Period | 75.34 | 85.81 | 165.78 | 176.19 | 201.87 |
| | | | | | |
| Equity Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 3.83 | 4.37 | 8.43 | 8.96 | 10.27 |
| Diluted EPS (Rs.) | 3.83 | 4.37 | 8.43 | 8.96 | 10.27 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 3.83 | 4.37 | 8.43 | 8.96 | 10.27 |
| Diluted EPS (Rs.) | 3.83 | 4.37 | 8.43 | 8.96 | 10.27 |
| | | | | | |
| PBITOE Margin (%) | 6.49 | 7.83 | 11.98 | 15.09 | 14.85 |
| PBTE Margin (%) | 5.82 | 7.38 | 11.84 | 14.44 | 14.65 |
| PBT Margin (%) | 5.82 | 7.38 | 12.65 | 14.44 | 14.65 |
| PAT Margin (%) | 4.79 | 6.10 | 10.49 | 11.94 | 13.69 |